Filter
117
Text search:
core
biopsy
Featured
22
32
Language
Document type
70
24
8
5
4
3
2
1
Countries
20
6
6
4
4
3
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
62
31
5
4
3
2
Toolboxes
17
11
5
5
4
4
2
2
1
1
1
1
1
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Sub-Saharan African Journal of Medicine: Year : 2014 | Volume : 1 | Issue : 1 | Page : 1-14
Policy and Manual
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Updated to Reflect the 2009 Medical Eligibility Criteria of the World Health Organization
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite
...
Prepared as an outcome of ICMR Subcommittee on Colorectal Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Colorectal Cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies,
supportive and palliative ca
...
These guidelines have been developed specifically to address ethical issues of conducting research in children.
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i
...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec
...
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro
...
Accessed Febr. 6, 2020
Accessed Febr. 6, 2020
